StockClub
KAPAKairos Pharma, Ltd.$ --
Kairos Pharma, Ltd.

Kairos Pharma, Ltd.

KAPA

$ -

-

You can review balance sheet highlights, composition, equity ratio trends, and annual balance sheet line items.

account_balanceBalance Sheet (BS) Summary

2024/12 Filed: 2025-04-15

Total Assets

account_balance
6.2M USD
No comparison

Shareholders' Equity

savings
4.8M USD
No comparison

Equity Ratio

pie_chart
76.8%
No comparison

Book Value Per Share

paid
0.23USD
No comparison

Asset & Liability Mix

Non-current AssetsCurrent AssetsEquityOtherNon-current LiabilitiesCurrent Liabilities

Equity Ratio Trend (5 Years)

Unit: %
806040200
2020
2021
2022
2023
2024

Balance Sheet Details

Item
2020
2021
2022
2023
2024
Cash
Cash and Equivalents
Short-term Investments
Net Receivables
Inventory
Other Current Assets
Total Current Assets
1.27M
1.27M
0
0
0
37,999
4.17M
Goodwill
Intangible Assets
Property, Plant and Equipment
Property, Plant and Equipment Net
Long-term Investments
Other Assets
Other Non-current Assets
Net Tangible Assets
Non-current Assets Total
Total Assets
0
222,000
0
0
0
0
1.38M
5.99M
2.05M
6.22M
Accounts Payable
Short-term Debt
Short/Current Long-term Debt
Current Deferred Revenue
Other Current Liabilities
Total Current Liabilities
0
0
0
0
992,000
992,000
Long-term Debt
Long-term Debt Total
Capital Lease Obligations
Other Non-current Liabilities
Net Debt
Non-current Liabilities Total
Total Liabilities
0
0
0
0
-1.27M
447,999
1.44M
Common Stock
Common Stock Shares Outstanding
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income
Other Stockholder Equity
Treasury Stock
Total Stockholder Equity
14,000
11.36M
13.58M
-8.81M
0
0
0
4.78M

Unlock Long-Term Balance Sheet Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.